ArticleFrontiers in endocrinology2020

Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.

Tsuyoshi Yanagimachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.